Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery

Colorectal cancer is one of the most commonly diagnosed cancers worldwide. The treatment consists of surgical resection, systemic chemotherapy, and new biological agents. One more recently emerging treatment option is oncolytic virotherapy. Although the use of the new treatment methods shows improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilgase, Andra, Olmane, Evija, Nazarovs, Jurijs, Brokāne, Linda, Erdmanis, Romualds, Rasa, Agnija, Alberts, Pēteris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167672/
https://www.ncbi.nlm.nih.gov/pubmed/30283278
http://dx.doi.org/10.1159/000492210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167672/
https://www.ncbi.nlm.nih.gov/pubmed/30283278
http://dx.doi.org/10.1159/000492210

Ejemplares similares